Design, Synthesis, and in Vitro Evaluation of Novel 3, 7-Disubstituted Coumarin Derivatives as Potent Anticancer Agents

Yubin Wang, Haitao Liu, Peng Lu, Rui Mao, Xiaojian Xue, Chen Fan, Jin-Xiong She

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Twenty-seven 3, 7-disubstituted coumarin derivatives were designed, synthesized, and evaluated in vitro as anticancer agents. Most of the compounds showed moderate-to-potent antiproliferative activity against K562 cells. Compounds 7b and 7d were chosen to evaluate the concentration of 50% growth inhibition (GI<inf>50</inf>) against SN12C, OVCAR, BxPC-3, KATO-III, T24, SNU-1, WiDr, HeLa, K562, and AGS cell lines. The most potent compound 7d was selected for further cell cycle arrest assay in the AGS cell line. The in vitro data indicated that methylation of benzimidazole moiety at the 3-position of coumarin exhibited significant enhancement of anticancer activity. This study should provide important information for further modification and optimization of coumarin derivatives as anticancer agents.

Original languageEnglish (US)
Pages (from-to)637-647
Number of pages11
JournalChemical Biology and Drug Design
Volume86
Issue number4
DOIs
StatePublished - Oct 1 2015
Externally publishedYes

Fingerprint

Coumarins
K562 Cells
Antineoplastic Agents
Cells
Cell Line
Cell Cycle Checkpoints
Methylation
Assays
Growth
In Vitro Techniques
coumarin
benzimidazole

Keywords

  • 3 7-disubstituted
  • anticancer activity
  • Coumarin
  • synthesis

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine

Cite this

Design, Synthesis, and in Vitro Evaluation of Novel 3, 7-Disubstituted Coumarin Derivatives as Potent Anticancer Agents. / Wang, Yubin; Liu, Haitao; Lu, Peng; Mao, Rui; Xue, Xiaojian; Fan, Chen; She, Jin-Xiong.

In: Chemical Biology and Drug Design, Vol. 86, No. 4, 01.10.2015, p. 637-647.

Research output: Contribution to journalArticle

Wang, Yubin ; Liu, Haitao ; Lu, Peng ; Mao, Rui ; Xue, Xiaojian ; Fan, Chen ; She, Jin-Xiong. / Design, Synthesis, and in Vitro Evaluation of Novel 3, 7-Disubstituted Coumarin Derivatives as Potent Anticancer Agents. In: Chemical Biology and Drug Design. 2015 ; Vol. 86, No. 4. pp. 637-647.
@article{f83faf0769ea475cb3d784850603bc3d,
title = "Design, Synthesis, and in Vitro Evaluation of Novel 3, 7-Disubstituted Coumarin Derivatives as Potent Anticancer Agents",
abstract = "Twenty-seven 3, 7-disubstituted coumarin derivatives were designed, synthesized, and evaluated in vitro as anticancer agents. Most of the compounds showed moderate-to-potent antiproliferative activity against K562 cells. Compounds 7b and 7d were chosen to evaluate the concentration of 50{\%} growth inhibition (GI50) against SN12C, OVCAR, BxPC-3, KATO-III, T24, SNU-1, WiDr, HeLa, K562, and AGS cell lines. The most potent compound 7d was selected for further cell cycle arrest assay in the AGS cell line. The in vitro data indicated that methylation of benzimidazole moiety at the 3-position of coumarin exhibited significant enhancement of anticancer activity. This study should provide important information for further modification and optimization of coumarin derivatives as anticancer agents.",
keywords = "3 7-disubstituted, anticancer activity, Coumarin, synthesis",
author = "Yubin Wang and Haitao Liu and Peng Lu and Rui Mao and Xiaojian Xue and Chen Fan and Jin-Xiong She",
year = "2015",
month = "10",
day = "1",
doi = "10.1111/cbdd.12531",
language = "English (US)",
volume = "86",
pages = "637--647",
journal = "Chemical Biology and Drug Design",
issn = "1747-0277",
publisher = "Blackwell",
number = "4",

}

TY - JOUR

T1 - Design, Synthesis, and in Vitro Evaluation of Novel 3, 7-Disubstituted Coumarin Derivatives as Potent Anticancer Agents

AU - Wang, Yubin

AU - Liu, Haitao

AU - Lu, Peng

AU - Mao, Rui

AU - Xue, Xiaojian

AU - Fan, Chen

AU - She, Jin-Xiong

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Twenty-seven 3, 7-disubstituted coumarin derivatives were designed, synthesized, and evaluated in vitro as anticancer agents. Most of the compounds showed moderate-to-potent antiproliferative activity against K562 cells. Compounds 7b and 7d were chosen to evaluate the concentration of 50% growth inhibition (GI50) against SN12C, OVCAR, BxPC-3, KATO-III, T24, SNU-1, WiDr, HeLa, K562, and AGS cell lines. The most potent compound 7d was selected for further cell cycle arrest assay in the AGS cell line. The in vitro data indicated that methylation of benzimidazole moiety at the 3-position of coumarin exhibited significant enhancement of anticancer activity. This study should provide important information for further modification and optimization of coumarin derivatives as anticancer agents.

AB - Twenty-seven 3, 7-disubstituted coumarin derivatives were designed, synthesized, and evaluated in vitro as anticancer agents. Most of the compounds showed moderate-to-potent antiproliferative activity against K562 cells. Compounds 7b and 7d were chosen to evaluate the concentration of 50% growth inhibition (GI50) against SN12C, OVCAR, BxPC-3, KATO-III, T24, SNU-1, WiDr, HeLa, K562, and AGS cell lines. The most potent compound 7d was selected for further cell cycle arrest assay in the AGS cell line. The in vitro data indicated that methylation of benzimidazole moiety at the 3-position of coumarin exhibited significant enhancement of anticancer activity. This study should provide important information for further modification and optimization of coumarin derivatives as anticancer agents.

KW - 3 7-disubstituted

KW - anticancer activity

KW - Coumarin

KW - synthesis

UR - http://www.scopus.com/inward/record.url?scp=84942502426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942502426&partnerID=8YFLogxK

U2 - 10.1111/cbdd.12531

DO - 10.1111/cbdd.12531

M3 - Article

C2 - 25626768

AN - SCOPUS:84942502426

VL - 86

SP - 637

EP - 647

JO - Chemical Biology and Drug Design

JF - Chemical Biology and Drug Design

SN - 1747-0277

IS - 4

ER -